RU2005121130A - Применение левоцетиризина для лечения устойчивого аллергического ринита - Google Patents
Применение левоцетиризина для лечения устойчивого аллергического ринита Download PDFInfo
- Publication number
- RU2005121130A RU2005121130A RU2005121130/14A RU2005121130A RU2005121130A RU 2005121130 A RU2005121130 A RU 2005121130A RU 2005121130/14 A RU2005121130/14 A RU 2005121130/14A RU 2005121130 A RU2005121130 A RU 2005121130A RU 2005121130 A RU2005121130 A RU 2005121130A
- Authority
- RU
- Russia
- Prior art keywords
- levocetirizine
- treatment
- pharmaceutically acceptable
- acceptable salt
- preparation
- Prior art date
Links
- ZKLPARSLTMPFCP-OAQYLSRUSA-N 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid Chemical compound C1CN(CCOCC(=O)O)CCN1[C@@H](C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-OAQYLSRUSA-N 0.000 title claims abstract 10
- 229960001508 levocetirizine Drugs 0.000 title claims abstract 10
- 206010039085 Rhinitis allergic Diseases 0.000 title claims abstract 4
- 201000010105 allergic rhinitis Diseases 0.000 title claims abstract 4
- 230000002085 persistent effect Effects 0.000 claims abstract 3
- 150000003839 salts Chemical class 0.000 claims 9
- 229940126601 medicinal product Drugs 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 2
- PGLIUCLTXOYQMV-GHVWMZMZSA-N 2-[2-[4-[(r)-(4-chlorophenyl)-phenylmethyl]piperazine-1,4-diium-1-yl]ethoxy]acetic acid;dichloride Chemical group Cl.Cl.C1CN(CCOCC(=O)O)CCN1[C@@H](C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 PGLIUCLTXOYQMV-GHVWMZMZSA-N 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 claims 1
- 208000036071 Rhinorrhea Diseases 0.000 claims 1
- 206010039101 Rhinorrhoea Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 229960003308 levocetirizine dihydrochloride Drugs 0.000 claims 1
- 206010041232 sneezing Diseases 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (9)
1. Применение левоцетиризина или его фармацевтически приемлемой соли для приготовления лекарственного средства, предназначенного для лечения устойчивого аллергического ринита.
2. Применение левоцетиризина или его фармацевтически приемлемой соли для приготовления лекарственного средства, предназначенного для уменьшения симптомов устойчивого аллергического ринита и улучшения качества жизни.
3. Применение левоцетиризина или его фармацевтически приемлемой соли для приготовления лекарственного средства, предназначенного для лечения ринореи.
4. Применение левоцетиризина или его фармацевтически приемлемой соли для приготовления лекарственного средства, предназначенного для лечения застоя в носовых проходах.
5. Применение левоцетиризина или его фармацевтически приемлемой соли для приготовления лекарственного средства, предназначенного для лечения жжения в носовых проходах.
6. Применение левоцетиризина или его фармацевтически приемлемой соли для приготовления лекарственного средства, предназначенного для лечения чихания.
7. Применение левоцетиризина или его фармацевтически приемлемой соли для приготовления лекарственного средства, предназначенного для лечения глазного зуда.
8. Применение по любому из пп.1-7, отличающееся тем, что соль представляет собой дигидрохлорид левоцетиризина.
9. Применение по любому из пп.1-7, отличающееся тем, что лекарственное средство адаптировано для введения дневной дозы от примерно 0,0005 мг до примерно 2 мг указанного левоцетиризина или указанной его фармацевтически приемлемой соли на кг веса пациента.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2080064.5 | 2002-12-03 | ||
| EP02080064 | 2002-12-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2005121130A true RU2005121130A (ru) | 2005-12-10 |
Family
ID=32405747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2005121130/14A RU2005121130A (ru) | 2002-12-03 | 2003-05-26 | Применение левоцетиризина для лечения устойчивого аллергического ринита |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US20060247258A1 (ru) |
| EP (1) | EP1569650B1 (ru) |
| JP (1) | JP2006509773A (ru) |
| KR (1) | KR20050085298A (ru) |
| CN (1) | CN1713912A (ru) |
| AT (1) | ATE396730T1 (ru) |
| AU (1) | AU2003238399B2 (ru) |
| BR (1) | BR0316823A (ru) |
| CA (1) | CA2506965A1 (ru) |
| CR (1) | CR7835A (ru) |
| CY (1) | CY1108191T1 (ru) |
| DE (1) | DE60321377D1 (ru) |
| DK (1) | DK1569650T3 (ru) |
| ES (1) | ES2304514T3 (ru) |
| HR (1) | HRP20050497B1 (ru) |
| MA (1) | MA27530A1 (ru) |
| MX (1) | MXPA05005795A (ru) |
| NO (1) | NO20053247L (ru) |
| NZ (1) | NZ540415A (ru) |
| PL (1) | PL377470A1 (ru) |
| PT (1) | PT1569650E (ru) |
| RU (1) | RU2005121130A (ru) |
| SI (1) | SI1569650T1 (ru) |
| TN (1) | TNSN05154A1 (ru) |
| WO (1) | WO2004050094A1 (ru) |
| ZA (1) | ZA200503703B (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20060484A1 (es) | 2004-07-14 | 2006-07-06 | Ucb Farchim Sa | Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina |
| US8513259B2 (en) | 2009-07-03 | 2013-08-20 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
| US8263581B2 (en) | 2009-07-03 | 2012-09-11 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2145410A1 (en) * | 1992-09-24 | 1994-03-31 | Nancy M. Gray | Compositions for treating allergic disorders using (-) cetirizine |
| US20030236275A1 (en) * | 2002-06-20 | 2003-12-25 | Schering Corporation | Treatment methods of nasal congestion and nasal obstruction |
-
2003
- 2003-05-26 US US10/536,939 patent/US20060247258A1/en not_active Abandoned
- 2003-05-26 WO PCT/EP2003/005491 patent/WO2004050094A1/en active IP Right Grant
- 2003-05-26 RU RU2005121130/14A patent/RU2005121130A/ru unknown
- 2003-05-26 DE DE60321377T patent/DE60321377D1/de not_active Revoked
- 2003-05-26 CN CNA038255448A patent/CN1713912A/zh active Pending
- 2003-05-26 EP EP03732466A patent/EP1569650B1/en not_active Revoked
- 2003-05-26 DK DK03732466T patent/DK1569650T3/da active
- 2003-05-26 KR KR1020057009991A patent/KR20050085298A/ko not_active Ceased
- 2003-05-26 AT AT03732466T patent/ATE396730T1/de not_active IP Right Cessation
- 2003-05-26 NZ NZ540415A patent/NZ540415A/en not_active IP Right Cessation
- 2003-05-26 HR HR20050497A patent/HRP20050497B1/xx not_active IP Right Cessation
- 2003-05-26 PT PT03732466T patent/PT1569650E/pt unknown
- 2003-05-26 MX MXPA05005795A patent/MXPA05005795A/es active IP Right Grant
- 2003-05-26 ZA ZA200503703A patent/ZA200503703B/xx unknown
- 2003-05-26 ES ES03732466T patent/ES2304514T3/es not_active Expired - Lifetime
- 2003-05-26 SI SI200331246T patent/SI1569650T1/sl unknown
- 2003-05-26 AU AU2003238399A patent/AU2003238399B2/en not_active Ceased
- 2003-05-26 JP JP2004556076A patent/JP2006509773A/ja active Pending
- 2003-05-26 CA CA002506965A patent/CA2506965A1/en not_active Abandoned
- 2003-05-26 BR BR0316823-9A patent/BR0316823A/pt not_active IP Right Cessation
- 2003-05-26 PL PL377470A patent/PL377470A1/pl not_active Application Discontinuation
-
2005
- 2005-05-11 CR CR7835A patent/CR7835A/es unknown
- 2005-05-26 MA MA28297A patent/MA27530A1/fr unknown
- 2005-06-02 TN TNP2005000154A patent/TNSN05154A1/en unknown
- 2005-07-01 NO NO20053247A patent/NO20053247L/no unknown
-
2008
- 2008-07-11 CY CY20081100732T patent/CY1108191T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1569650E (pt) | 2008-06-26 |
| AU2003238399B2 (en) | 2009-05-07 |
| DE60321377D1 (de) | 2008-07-10 |
| CN1713912A (zh) | 2005-12-28 |
| ES2304514T3 (es) | 2008-10-16 |
| HRP20050497B1 (hr) | 2008-10-31 |
| EP1569650A1 (en) | 2005-09-07 |
| US20060247258A1 (en) | 2006-11-02 |
| AU2003238399A1 (en) | 2004-06-23 |
| CA2506965A1 (en) | 2004-06-17 |
| ZA200503703B (en) | 2006-10-25 |
| NZ540415A (en) | 2008-06-30 |
| TNSN05154A1 (en) | 2007-05-14 |
| HRP20050497A2 (en) | 2005-12-31 |
| DK1569650T3 (da) | 2008-06-30 |
| CR7835A (es) | 2008-12-01 |
| BR0316823A (pt) | 2005-10-18 |
| CY1108191T1 (el) | 2012-05-23 |
| WO2004050094A1 (en) | 2004-06-17 |
| SI1569650T1 (sl) | 2008-08-31 |
| KR20050085298A (ko) | 2005-08-29 |
| NO20053247D0 (no) | 2005-07-01 |
| MA27530A1 (fr) | 2005-09-01 |
| PL377470A1 (pl) | 2006-02-06 |
| EP1569650B1 (en) | 2008-05-28 |
| ATE396730T1 (de) | 2008-06-15 |
| NO20053247L (no) | 2005-07-01 |
| MXPA05005795A (es) | 2005-08-16 |
| JP2006509773A (ja) | 2006-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023041862A5 (ru) | ||
| FI1663240T4 (fi) | Pyrimidiiniä sisältävän nnrti:n yhdistelmiä rt-estäjien kanssa | |
| US20060039867A1 (en) | Method for treating sleep-related breathing disorders with setiptiline | |
| PT1173178E (pt) | Composicao compreendendo apomorfina e sildenafil e utilizacao da mesma para o tratamento da disfuncao erectil | |
| NZ527113A (en) | Rapid-onset medicament for the treatment of sexual dysfunction | |
| NZ593467A (en) | Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof | |
| HRP20120798T1 (hr) | Kappa-opijatni agonisti za lijeäśenje dijareja-predominantnog i naizmjeniäśnog sindroma iritabilnog crijeva | |
| JP2011520981A5 (ru) | ||
| EA200700214A1 (ru) | Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией | |
| JP2002528502A5 (ru) | ||
| EP4442321A3 (en) | Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor | |
| AU755402B2 (en) | Method of treating impotence due to spinal cord injury | |
| KR20050085681A (ko) | 프로테아제 억제제와 같은 사이토크롬 ｐ450의 억제제와함께 비-뉴클레오시드 역전사효소 억제제(ｎｎｒｔｉ)를함유하는 배합물의 용도 | |
| JP2015523986A5 (ru) | ||
| ES2390226T3 (es) | Tratamiento de enfermedades infecciosas | |
| RU2007119067A (ru) | Средство для лечения синдрома раздраженного кишечника с преобладанием диареи | |
| RU2005121130A (ru) | Применение левоцетиризина для лечения устойчивого аллергического ринита | |
| BRPI0415322A (pt) | composição farmacêutica antiretroviral, processo para a preparação de uma composição farmacêutica antiretroviral, método para reduzir a carga de consumo de pìlulas para um paciente, método para aumentar a meia-vida in vivo de lamivudina e de zidovudina enquanto não afetando a meia-vida de nevirapina | |
| MX2024006270A (es) | Nueva composicion farmaceutica oral y regimen de dosificacion para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| US20190224208A1 (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
| AU2002363874A1 (en) | Use of desoxypeganine for treating clinical depression | |
| WO2023096615A3 (en) | A compressed solid oral dosage form comprising pinaverium and medazepam | |
| US20090124606A1 (en) | Composition for Treatment of Psychosis | |
| RU2007116726A (ru) | Применение лавандового масла для профилактики и лечения неврастении, соматических нарушений и других болезней, связанных со стрессом | |
| RU2006110550A (ru) | Применение окскарбазепина для лечения диабетической нейропатической боли и для улучшения сна |